S. Guler (Bern, Switzerland), B. Crestani (Paris, France)
This session is built from abstracts published on the ERS Congress platform from 23 August, in an e-poster pdf format with a 3-minute audio narration. Participants and chairs of the session are invited to access all e-posters from 23 August to 4 September prior to the 1-hour live, online discussion scheduled from September 5-7. Please note that during live discussion there will be NO e-poster/abstract presentations, only discussion.
Enabling an interstitial lung disease genomic classifier on an automated platform H. Jiang (South San Francisco, United States of America), C. Schaper (South San Francisco, United States of America), J. Qu (South San Francisco, United States of America), N. Davis (South San Francisco, United States of America), G. Fedorowicz (South San Francisco, United States of America), M. Naranja (South San Francisco, United States of America), K. Lee (South San Francisco, United States of America), J. Storhoff (South San Francisco, United States of America), D. Pankratz (South San Francisco, United States of America), A. Sopory (South San Francisco, United States of America), S. Bhorade (South San Francisco, United States of America), J. Huang (South San Francisco, United States of America), S. Walsh (South San Francisco, United States of America), G. Kennedy (South San Francisco, United States of America)
| |
TERT expression in lung cancer associated with IPF: a case-control study G. Gomatou (Athens, Greece), C. Masaoutis (Athens, Greece), I. Vamvakaris (Athens, Greece), E. Bouros (Athens, Greece), D. Bouros (Athens, Greece)
| |
Radiological scores in IPF patients according to MUC5B polymorphism. E. Cocconcelli (Padova (PD), Italy), N. Bernardinello (Padova (PD), Italy), C. Giraudo (Padova (PD), Italy), C. Greco (Padova (PD), Italy), A. Fraia (Padova (PD), Italy), A. Achille (Padova (PD), Italy), M. Saetta (Padova (PD), Italy), E. Balestro (Padova (PD), Italy), P. Spagnolo (Padova (PD), Italy)
| |
Interstitial lung abnormalities with a diagnosis of idiopathic pulmonary fibrosis T. Bando (Seto, Japan), R. Takei (Seto, Japan), Y. Yamano (Seto, Japan), T. Yokoyama (Seto, Japan), T. Matsuda (Seto, Japan), K. Kataoka (Seto, Japan), T. Kimura (Seto, Japan), T. Johkoh (Amagasaki, Japan), J. Fukuoka (Nagasaki, Japan), Y. Kondoh (Seto, Japan)
| |
The role of CX3CL1 and ADAM17 in pathogenesis of diffuse parenchymal lung diseases E. Tedlova (Bratislava, Slovakia), J. Urban (Vysne Hagy, Slovakia), M. Suchankova (Bratislava, Slovakia), M. Ganovska (Vysne Hagy, Slovakia), V. Leksa (Bratislava, Slovakia), F. Sandor (Bratislava, Slovakia), B. Konig (Bratislava, Slovakia), I. Jonner (Vysne Hagy, Slovakia), M. Bucova (Bratislava, Slovakia)
| |
Effect of pirfenidone on the development of pellagra-related nausea in mice K. Kuronuma (Sapporo, Japan), N. Susai (Toyonaka, Japan), T. Ishikawa (Sapporo, Japan), T. Kuroita (Toyonaka, Japan), T. Yoshioka (Toyonaka, Japan)
| |
Effect of thymus vulgaris leaf extract on bleomycin induced oxidative stress and lung fibrosis in rats S. BAHRI (Tunis, Tunisia), M. Mlika (Tunis, Tunisia), A. Nahdi (Tunis, Tunisia), S. Jameleddine (Tunis, Tunisia)
| |
Real world data analysis indicates that pirfenidone may cause pellagra-like photosensitivity T. Kuroita (Toyonaka, Japan), H. Yamamoto (Kyoto, Japan), N. Susai (Toyonaka, Japan), T. Yoshioka (Toyonaka, Japan), K. Kuronuma (Sapporo, Japan), S. Kaneko (Kyoto, Japan)
| |
Surface enolase-1 mediated cell migration and lung fibrosis in bleomycin-induced mice W. Huang (Taipei, Taiwan), C. Chuang (Taipei, Taiwan), I. Chung (Taipei, Taiwan), Y. Huang (Taipei, Taiwan), M. Chen (Taipei, Taiwan), T. Yuan (Taipei, Taiwan)
| |
NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis M. Kreus (Oulu, Finland), S. Lehtonen (Oulu, Finland), J. Salonen (Oulu, Finland), R. Hinttala (Oulu, Finland), R. Kaarteenaho (Oulu, Finland)
| |
Prolyl-3-hydroxylase 4 (P3H4), a novel player in collagen synthesis and secretion in lung fibroblasts C. Onursal (München, Germany), L. Knüppel (München, Germany), J. Merl-Pham (München, Germany), C. D. Lietman (Houston, Texas, United States of America), R. Hatz (München, Germany), J. Behr (München, Germany), K. Unger (München, Germany), J. Hess (München, Germany), S. Hauck (München, Germany), B. Lee (Houston, Texas, United States of America), C. Staab-Weijnitz (München, Germany)
| |
The impact of idiopathic pulmonary fibrosis on the airway length per generation in the human lung V. Geudens (Leuven, Belgium), C. Aelbrecht (Leuven, Belgium), J. Kaes (Leuven, Belgium), J. Van Slambrouck (Leuven, Belgium), T. Goos (Leuven, Belgium), A. Vanstapel (Leuven, Belgium), G. Aerts (Leuven, Belgium), I. Gyselinck (Leuven, Belgium), L. J. De Sadeleer (Leuven, Belgium), S. E. Verleden (Leuven, Belgium), G. M. Verleden (Leuven, Belgium), W. Janssens (Leuven, Belgium), R. Vos (Leuven, Belgium), L. J. Ceulemans (Leuven, Belgium), G. Gayan-Ramirez (Leuven, Belgium), B. M. Vanaudenaerde (Leuven, Belgium), W. A. Wuyts (Leuven, Belgium)
| |
Anti–fibrotic efficacy of Lck inhibitor via the suppression of TGF–ß production in regulatory T cells K. Kagawa (Tokushima, Japan), K. Koyama (Tokushima, Japan), S. Sato (Tokushima, Japan), T. Imakura (Tokushima, Japan), K. Murakami (Tokushima, Japan), N. Takahashi (Tokushima, Japan), N. Naito (Tokushima, Japan), H. Nishimura (Tokushima, Japan), H. Kawano (Tokushima, Japan), Y. Nishioka (Tokushima, Japan)
| |
Aging decreases reversibility of pulmonary fibrosis by regulating PRDM16-related fatty acid metabolism in lung fibroblasts Y. Zhang (Guangzhou, China), Y. Meng (Guangzhou, China)
| |
Effects of coronavirus disease 2019 (COVID-19) pandemic on the follow-up and treatment of patients with idiopathic pulmonary fibrosis: a cross-sectional multicenter study phone call survey N. Coskun (Bursa, Turkey), I. Hanta (Adana, Turkey), A. Çilli (Antalya, Turkey), G. Özkaya (Bursa, Turkey), A. Ursavas (Bursa, Turkey), C. Sevinc (Izmir, Turkey)
| |
Interstitial lung abnormalities after SARS-COV2 infection D. Badenes Bonet (Barcelona, Spain), O. Caguana Velez (Barcelona, Spain), C. Cumplí Gargallo (Barcelona, Spain), J. González García (Barcelona, Spain), F. Zuccarino (Barcelona, Spain), J. Martínez Llorens (Barcelona, Spain), J. Villar (Barcelona, Spain), J. Gea Guiral (Barcelona, Spain), D. Rodríguez Chiaradia (Barcelona, Spain), E. Balcells Vilarnau (Barcelona, Spain)
| |
FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION O. Caguana Velez (Barcelona, Spain), D. Badenes (Barcelona, Spain), F. Zuccarino (Barcelona, Spain), L. Del Carpio Bellido (Barcelona, Spain), D. Rodríguez-Chiaradía (Barcelona, Spain), M. Domínguez (Barcelona, Spain), J. Gea (Barcelona, Spain), E. Balcells (Barcelona, Spain)
| |
Basement membrane remodeling is related to disease progression and severity in idiopathic pulmonary fibrosis H. Jessen (Herlev, Denmark), N. Hoyer (Hellerup, Denmark), T. Prior (Aarhus, Denmark), P. Frederiksen (Herlev, Denmark), M. Karsdal (Herlev, Denmark), D. Leeming (Herlev, Denmark), E. Bendstrup (Aarhus, Denmark), J. Sand (Herlev, Denmark), S. Shaker (Hellerup, Denmark)
| |